Pharmacological effects of Ibuprofen on learning and memory, muscarinic receptors gene expression and APP isoforms level in pre-frontal cortex of AlCl₃-induced toxicity mouse model

References

• Abd-Elhady RM, Elsheikh AM, Khalifa AE. Anti-amnestic properties of Ginkgo biloba extract on impaired memory function induced by aluminum in rats. Int J Dev Neurosci 2013;31(7):598–607.
   PubMed Web of Science ®Google Scholar
• Belyaeva EA, Sokolova TV, Emelyanova LV, Zakharova IO. Mitochondrial electron transport chain in heavy metal-induced neurotoxicity: effects of cadmium, mercury, and copper. Sci World J 2012;2012:136063.
   Google Scholar
• Pohl HR, Roney N, Abadin HG. Metal ions affecting the neurological system. Met Life Sci 2011;8:247–62.
   PubMedGoogle Scholar
• Suarez-Fernandez MB, Soldado AB, Sanz-Medel A, et al. Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain Res 1999;835(2):125–36.
   PubMed Web of Science ®Google Scholar
• Platt B, Fiddler G, Riedel G, Henderson Z. Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain Res Bull 2001;55(2):257–67.
   PubMed Web of Science ®Google Scholar
• Afifi A. Renal osteodystrophy in developing countries. Artif Organs 2002;26(9):767–9.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang M, Ruan D, She J. Early chronic aluminium exposure impairs long-term potentiation and depression to the rat dentate gyrus in vivo. Neuroscience 2002;112(4):879–87.
   PubMed Web of Science ®Google Scholar
• Walton JR. Chronic aluminum intake causes Alzheimer's Disease: applying Sir Austin Bradford Hill's Causality Criteria. J Alzheimers Dis 2014;40(4):765–838.
   PubMed Web of Science ®Google Scholar
• Altmann P, Cunningham J, Dhanesha U, et al. Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident. BMJ 1999;319(7213):807–11.
   PubMed Web of Science ®Google Scholar
• Bondy SC. The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology 2010;31(5):575–81.
   PubMed Web of Science ®Google Scholar
• Andrasi E, Pali N, Molnar Z, Kosel S. Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients. J Alzheimers Dis 2005;7(4):273–84.
   PubMed Web of Science ®Google Scholar
• LaFerla FM, Oddo S. Alzheimer's disease: Abeta, tau and synaptic dysfunction. Trends Mol Med 2005;11(4):170–6.
   PubMed Web of Science ®Google Scholar
• Sastre M, Klockgether T, Heneka MT. Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int J Dev Neurosci 2006;24(2–3):167–76.
   PubMed Web of Science ®Google Scholar
• Andersen K, Launer LJ, Ott A, et al. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 1995;45(8):1441–5.
   PubMed Web of Science ®Google Scholar
• Ban EM. lnterleukin-1 receptors in the brain: characterization by quantitative in situ autoradiography. Immunomethods 1994;5:31–40.
   PubMedGoogle Scholar
• Yu L, Jiang R, Su Q, et al. Hippocampal neuronal metal ion imbalance related oxidative stress in a rat model of chronic aluminum exposure and neuroprotection of meloxicam. Behav Brain Funct 2014;10:6.
   PubMed Web of Science ®Google Scholar
• Julka D, Sandhir R, Gill KD. Altered cholinergic metabolism in rat CNS following aluminum exposure: implications on learning performance. J Neurochem 1995;65(5):2157–64.
   PubMed Web of Science ®Google Scholar
• Levey AI. Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. Proc Natl Acad Sci USA 1996;93(24):13541–6.
   PubMed Web of Science ®Google Scholar
• Ahmed T, Gilani AH. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease. Pharmacol Biochem Behav 2009;91(4):554–9.
   PubMed Web of Science ®Google Scholar
• Rossner S, Ueberham U, Schliebs R, et al. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog Neurobiol 1998;56(5):541–69.
   PubMed Web of Science ®Google Scholar
• Apelt J, Schliebs R, Beck M, et al. Expression of amyloid precursor protein mRNA isoforms in rat brain is differentially regulated during postnatal maturation and by cholinergic activity. Int J Dev Neurosci 1997;15(1):95–112.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001;81(2):741–66.
   PubMed Web of Science ®Google Scholar
• Bordji K, Becerril-Ortega J, Nicole O, Buisson A. Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ss production. J Neurosci 2010;30(47):15927–42.
   PubMed Web of Science ®Google Scholar
• LeBlanc AC, Chen HY, Autilio-Gambetti L, Gambetti P. Differential APP gene expression in rat cerebral cortex, meninges, and primary astroglial, microglial and neuronal cultures. FEBS Lett 1991;292(1–2):171–8.
   PubMed Web of Science ®Google Scholar
• Mahdi F, Van Nostrand WE, Schmaier AH. Protease nexin-2/amyloid beta-protein precursor inhibits factor Xa in the prothrombinase complex. J Biol Chem 1995;270(40):23468–74.
   PubMed Web of Science ®Google Scholar
• Ho L, Fukuchi K, Younkin SG. The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells. J Biol Chem 1996;271(48):30929–34.
   PubMed Web of Science ®Google Scholar
• Yan Q, Zhang J, Liu H, et al. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci 2003;23(20):7504–9.
   PubMed Web of Science ®Google Scholar
• Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21(3):383–421.
   PubMed Web of Science ®Google Scholar
• Breitner JC, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44(2):227–32.
   PubMed Web of Science ®Google Scholar
• Alafuzoff I, Overmyer M, Helisalmi S, Soininen H. Lower counts of astroglia and activated microglia in patients with Alzheimer's Disease with regular use of non-steroidal anti-inflammatory drugs. J Alzheimers Dis 2000;2(1):37–46.
   PubMedGoogle Scholar
• Gasparini L, Ongini E, Wilcock D, Morgan D. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease. Brain Res Brain Res Rev 2005;48(2):400–8.
   PubMedGoogle Scholar
• Lim GP, Yang F, Chu T, et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 2000;20(15):5709–14.
   PubMed Web of Science ®Google Scholar
• Etminan M, Gill S, Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ 2003;327(7407):128–32.
   PubMed Web of Science ®Google Scholar
• Rebai O, Djebli EN. Chronic exposure to aluminum chloride in mice: exploratory behaviors and spatial learning. Adv Biol Res 2008;2(1–2):26–33.
   Google Scholar
• Lee S, Ahmed T, Lee S, et al. Bidirectional modulation of fear extinction by mediodorsal thalamic firing in mice. Nat Neurosci 2012;15(2):308–14.
   Web of Science ®Google Scholar
• Wood SC, Anagnostaras SG. Interdependence of measures in pavlovian conditioned freezing. Neurosci Lett 2011;505(2):134–9.
   PubMed Web of Science ®Google Scholar
• Moy SS, Nadler JJ, Perez A, et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004;3(5):287–302.
   PubMed Web of Science ®Google Scholar
• Ennaceur A, Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 1988;31(1):47–59.
   PubMed Web of Science ®Google Scholar
• Deacon R. Assessing burrowing, nest construction, and hoarding in mice. J Vis Exp 2012;(59):e2607.
   Google Scholar
• Ahmed T, Enam SA, Gilani AH. Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease. Neuroscience 2010;169(3):1296–306.
   PubMed Web of Science ®Google Scholar
• Walton JR. Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment. Int J Alzheimers Dis 2012;2012:914947.
   PubMedGoogle Scholar
• Kawahara M. Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimers Dis 2005;8(2):171–82; discussion 209–15.
   PubMed Web of Science ®Google Scholar
• Kawahara M, Kato-Negishi M. Link between aluminum and the pathogenesis of alzheimer's disease: the integration of the aluminum and amyloid cascade hypotheses. Int J Alzheimers Dis 2011;2011:276393.
   PubMedGoogle Scholar
• Morita A, Kimura M, Itokawa Y. The effect of aging on the mineral status of female mice. Biol Trace Elem Res 1994;42(2):165–77.
   PubMed Web of Science ®Google Scholar
• Bartzokis G, Beckson M, Hance DB, et al. MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging 1997;15(1):29–35.
   PubMed Web of Science ®Google Scholar
• Yokel RA. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J Alzheimers Dis 2006;10(2–3):223–53.
   PubMed Web of Science ®Google Scholar
• Abu-Taweel GM, Ajarem JS, Ahmad M. Neurobehavioral toxic effects of perinatal oral exposure to aluminum on the developmental motor reflexes, learning, memory and brain neurotransmitters of mice offspring. Pharmacol Biochem Behav 2012;101(1):49–56.
   PubMed Web of Science ®Google Scholar
• Bushra R, Aslam N. An overview of clinical pharmacology of Ibuprofen. Oman Med J 2010;25(3):155–1661.
   PubMedGoogle Scholar
• Parepally JM, Mandula H, Smith QR. Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin. Pharm Res 2006;23(5):873–81.
   PubMed Web of Science ®Google Scholar
• in t’ Veld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001;345(21):1515–21.
   PubMed Web of Science ®Google Scholar
• McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996;47(2):425–32.
   PubMed Web of Science ®Google Scholar
• Rudy JW, Biedenkapp JC, O’Reilly RC. Prefrontal cortex and the organization of recent and remote memories: an alternative view. Learn Mem 2005;12(5):445–6.
   PubMed Web of Science ®Google Scholar
• Kaufman LD, Pratt J, Levine B, Black SE. Executive deficits detected in mild Alzheimer's disease using the antisaccade task. Brain Behav 2012;2(1):15–21.
   PubMed Web of Science ®Google Scholar
• Anagnostaras SG, Murphy GG, Hamilton SE, et al. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 2003;6(1):51–8.
   PubMed Web of Science ®Google Scholar
• Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 2004;44:423–50.
   PubMed Web of Science ®Google Scholar
• Levey AI, Kitt CA, Simonds WF, et al. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 1991;11(10):3218–26.
   PubMed Web of Science ®Google Scholar
• Langmead CJ, Watson J, Reavill C. Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther 2008;117(2):232–43.
   PubMed Web of Science ®Google Scholar
• Ladner CJ, Lee JM. Reduced high-affinity agonist binding at the M1 muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations. Exp Neurol 1999;158(2):451–8.
   PubMed Web of Science ®Google Scholar
• Shiozaki K, Iseki E. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease. J Neurol Sci 2004;223(2):145–8.
   PubMed Web of Science ®Google Scholar
• Tsang SW, Lai MK, Kirvell S, et al. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease. Neurobiol Aging 2006;27(9):1216–23.
   PubMed Web of Science ®Google Scholar
• Lai MK, Lai OF, Keene J, et al. Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex. Neurology 2001;57(5):805–11.
   PubMed Web of Science ®Google Scholar
• Haring R, Fisher A, Marciano D, et al. Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion. J Neurochem 1998;71(5):2094–103.
   PubMed Web of Science ®Google Scholar
• Hartmann T, Runz M, Grimm H, et al. γ-secretase inhibition via cholesterol depletion involves presenilin. Soc Neurosci Abstr 2002:122.6.
   Google Scholar
• Fisher A, Pittel, Z, Haring R, et al. M1 muscarinic agonists can modulate some of the hallmarks of Alzheimer's disease. J Mol Neurosci 2003:349–56.
   PubMed Web of Science ®Google Scholar
• Seeger T, Fedorova I, Zheng F, et al. M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. J Neurosci 2004;24(45):10117–27.
   PubMed Web of Science ®Google Scholar
• Poulin B, Butcher A, McWilliams P, et al. The M3-muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent manner. Proc Natl Acad Sci USA 2010;107(20):9440–5.
   PubMed Web of Science ®Google Scholar
• Hein AM, Stutzman DL, Bland ST, et al. Prostaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampus. Neuroscience 2007;150(4):754–63.
   PubMed Web of Science ®Google Scholar
• Pietropaolo S, Delage P, Lebreton F, et al. Early development of social deficits in APP and APP-PS1 mice. Neurobiol Aging 2012;33(5):1002 e17–27.
   Web of Science ®Google Scholar
• Jicha GA, Carr SA. Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease. J Alzheimers Dis 2010;19(1):253–72.
   PubMed Web of Science ®Google Scholar
• Mohs RC, Schmeidler J, Aryan M. Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease. Stat Med 2000;19(11–12):1401–9.
   PubMed Web of Science ®Google Scholar
• Rankin KP, Santos-Modesitt W, Kramer JH, et al. Spontaneous social behaviors discriminate behavioral dementias from psychiatric disorders and other dementias. J Clin Psychiatry 2008;69(1):60–73.
   PubMed Web of Science ®Google Scholar
• Araya R, Noguchi T, Yuhki M, et al. Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiol Dis 2006;24(2):334–44.
   PubMed Web of Science ®Google Scholar
• Meziane H, Dodart JC, Mathis C, et al. Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci USA 1998;95(21):12683–8.
   PubMed Web of Science ®Google Scholar
• Yasojima K, McGeer EG, McGeer PL. Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain. Brain Res 2001;919(1):115–21.
   PubMed Web of Science ®Google Scholar
• Chua LM, Lee CW, Jacqueline ZEH, Wong BS. Kunitz protease inhibitor-containing amyloid precursor protein isoforms impaired mitochondrial function. Faseb J 2008;22:823.10.
   Web of Science ®Google Scholar
• Matsui T, Ingelsson M, Fukumoto H, et al. Expression of APP pathway mRNAs and proteins in Alzheimer's disease. Brain Res 2007;1161:116–23.
   PubMed Web of Science ®Google Scholar
• Herskowitz JH, Feng Y, Mattheyses AL, et al. Pharmacologic inhibition of ROCK2 suppresses amyloid-beta production in an Alzheimer's disease mouse model. J Neurosci 2013;33(49):19086–98.
   PubMed Web of Science ®Google Scholar
• Kamenetz F, Tomita T, Hsieh H, et al. APP processing and synaptic function. Neuron 2003;37(6):925–37.
   PubMed Web of Science ®Google Scholar
• Davis AA, Fritz JJ, Wess J, et al. Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo. J Neurosci 2010;30(12):4190–6.
   PubMed Web of Science ®Google Scholar
• Gil-Bea FJ, Gerenu G, Aisa B, et al. Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice. Neurobiol Dis 2012;48(3):439–46.
   PubMed Web of Science ®Google Scholar
• Klegeris A, Maguire J, McGeer PL. S- but not R-enantiomers of flurbiprofen and ibuprofen reduce human microglial and THP-1 cell neurotoxicity. J Neuroimmunol 2004;152(1–2):73–7.
   PubMed Web of Science ®Google Scholar
• Morihara T, Chu T, Ubeda O, et al. Selective inhibition of Abeta42 production by NSAID R-enantiomers. J Neurochem 2002;83(4):1009–12.
   PubMed Web of Science ®Google Scholar